Bimonthly 24 h infusion of high-dose 5-fluorouracil vs EAP regimen in patients with advanced gastric cancer: A randomized phase II study

Medical Oncology

Volumn 25, Issue 1, 2008, Pages 73-80

  Popov, I P ^a   Jelic S B ^a   Krivokapic Z V ^b   Jezdic S D ^a   Pesko P M ^b   Micev, M T ^b   Babic D R ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Advanced disease; Chemotherapy; Gastric cancer; Infusional 5 fluorouracil

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; EAP PROTOCOL;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BLEEDING; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; GRANULOCYTE; HAND FOOT SYNDROME; HEART ARREST; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SEPTIC SHOCK; SIDE EFFECT; STOMACH CANCER; STOMATITIS; THROMBOCYTE; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING; DISEASE COURSE; DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; STOMACH TUMOR;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DISEASE PROGRESSION; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 42949161203     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-007-0042-8     Document Type: Article

References (24)

1. Iveson T, Cunningham D. Gastric cancer. In: Cavalli F, Hansen HH, Kaye SB (eds). Textbook of medical oncology. Martin Dunitz Ltd., London, 1997, pp. 161-164.
2. Yao JC, et al. (2003) Combined-modality therapy for gastric cancer. Semin Surg Oncol. 21(4):223-227.
3. J. Wils 1996 The treatment of advanced gastric cancer Semin Onc 23 3 397 406
4. Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol2003; 14(Suppl 2):ii31-36.
5. CS. Fuchs 1997 Chemotherapy for advanced gastric cancer: where do we stand? J Clin Oncol 15 11 3299 3300
6. KG. Janunger L. Hafstrom B. Glimelius 2002 Chemotherapy in gastric cancer: a review and updated meta-analysis Eur J Surg 168 11 597 608
7. D. Kelsen 1992 FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer J Clin Oncol 10 541 548
8. I. Popov 2000 Eight-hour infusion versus bolus injection of doxorubicin in EAP regimen in patients with advanced gastric cancer: a prospective randomised trial Ann Oncol 11 343 348
9. Sencan O, et al. Comparison of 5-fluorouracil-folinic acid and etoposide-doxorubicin-cisplatin chemotherapies in patients with advanced gastric carcinoma: a prospective randomized crossover study, interim analysis. Ann Oncol2000; 11(Suppl 4):70.
10. Meta-analysis Group in Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol1998; 16:301-308.
11. NCI-Common Toxicity Criteria. National Cancer Institute, Division of Cancer Treatment 1994 (revised). Popov et al.
12. P. Therasse 2000 New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 3 205 216
13. AM. Murad 1993 Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer 72 37 41
14. Macdonald JS. Advances in the therapy of gastric cancer. Gastric Cancer2002; 5(Suppl 1):35-40.
15. S. Cascinu 1997 Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer J Clin Oncol 15 3313 3319
16. Cocconi G, et al. Cisplatin, epirubicin, leucovorin and 5-flu-orouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma. Ann Oncol2003; 14(8):1258-1263.
17. JS. Waters 1999 Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial Br J Cancer 80 1-2 269 272
18. Vanhoefer U, et al. High-dose 5-fluorouracil/folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study. Eur J Cancer 2001; 37(Suppl 6):27.
19. RD. Hofheinz 2002 High-dose 5-fluorouracil/folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer A phase II study. Onkologie 25 3 255 260
20. KH. Yeh SH. Yeh CH. Hsu TM. Wang IF. Ma AL. Cheng 2000 Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil Br J Cancer 83 11 1510 1515
21. Wils J. Chemotherapy of metastatic gastric cancer. Gan To Kagaku Ryoho2000; 27(Suppl 2):395-398.
22. Goldberg RM. Gastroesophageal cancers: forward motion? Education book for ASCO meeting 2000, pp. 504-510.
23. Roth AD, et al. Docetaxel (Taxotere)-cisplatin (TC): An effective drug combination in gastric cancer. Ann Oncol2000; 11:301-306.
24. K. Ridwelski 2001 Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer Ann Oncol 12 47 51